THE EFFECT OF OUT-OF-POCKET COST DISCUSSIONS ON WILLINGNESS TO TAKE SACUBITRIL VALSARTAN FOR HEART FAILURE

被引：0
|
作者：
Speight, Candace [1 ]
Allen, Larry [1 ]
Halpern, Scott [1 ]
Ko, Yi-An [1 ]
Matlock, Daniel [1 ]
Moore, Miranda [1 ]
Morris, Alanna [1 ]
Rao, Birju [1 ]
Scherer, Laura [1 ]
Thomson, Mary Catherine [1 ]
Ubel, Peter [1 ]
Dickert, Neal [1 ]
机构：
[1] Emory Univ, Sch Med, Atlanta, GA USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2021年 / 77卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：870 / 870
页数：1
相关论文
共 50 条
  • [41] Effect of sacubitril/valsartan on natriuretic peptide in patients with compensated heart failure
    Shirakabe, Akihiro
    Matsushita, Masato
    Sawatani, Tomofumi
    Noma, Satsuki
    Takayasu, Tsutomu
    Kanai, Hideki
    Asano, Miwako
    Nomura, Akiko
    Asai, Kuniya
    HEART AND VESSELS, 2023, 38 (06) : 773 - 784
  • [42] Effect of Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure
    Solomon, Scott D.
    Lund, Lars
    Packer, Milton
    Rouleau, Jean L.
    Zile, Michael R.
    Swedberg, Karl B.
    Sweitzer, Nancy K.
    Desai, Akshay S.
    Kober, Lars
    Lefkowitz, Marty
    Linssen, Gerard C.
    Anand, Inder S.
    McMurray, John J.
    CIRCULATION, 2019, 140 (25) : E995 - E995
  • [43] REPLY: Adoption of Sacubitril/Valsartan Must Take Into Account Different Heart Failure Patient Types
    Luo, Nancy
    Mentz, Robert J.
    O'Brien, Emily C.
    JACC-HEART FAILURE, 2017, 5 (09) : 689 - 689
  • [44] OUT-OF-POCKET COST IN RAILROAD FREIGHT RATES
    Wilson, G. Lloyd
    Rose, J. R.
    QUARTERLY JOURNAL OF ECONOMICS, 1946, 60 (04): : 546 - 560
  • [45] Prior Heart Failure Hospitalization, Clinical Outcomes, and Effect of Sacubitril/Valsartan Compared With Valsartan in Heart Failure With Preserved Ejection Fraction
    Vaduganathan, Muthiah
    Claggett, Brian
    Anker, Stefan D.
    Perrone, Sergio V., Sr.
    Janssens, Stefan P.
    Milicic, Davor
    Arango, Juan L.
    Packer, Milton
    McMurray, John J.
    Solomon, Scott
    CIRCULATION, 2019, 140 (25) : E995 - E996
  • [46] Sacubitril/valsartan in heart failure with reduced ejection fraction: cost and effectiveness in the Italian context
    D'Angiolella, Lucia S.
    Cortesi, Paolo A.
    Pitotti, Claudia
    Ritrovato, Daniela
    Mantovani, Lorenzo G.
    Senni, Michele
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 (11) : 1551 - 1553
  • [47] COST-EFFECTIVENESS OF SACUBITRIL/VALSARTAN IN HEART FAILURE WITH REDUCED EJECTION FRACTION IN SWEDEN
    Costa-Scharplatz, M.
    Lang, A.
    McMurray, J. J.
    Woodcock, F.
    Haroun, R.
    Johansson, D.
    Lund, L. H.
    VALUE IN HEALTH, 2016, 19 (07) : A650 - A651
  • [48] COST-UTILITY ANALYSIS OF SACUBITRIL/VALSARTAN FOR THE TREATMENT OF CHRONIC HEART FAILURE IN GREECE
    Stafylas, P.
    Farmakis, D.
    Kourlaba, G.
    Giamouzis, G.
    Chatzikou, M.
    Kossiva, E.
    Maniadakis, N.
    Parissis, J.
    VALUE IN HEALTH, 2016, 19 (07) : A654 - A654
  • [49] The cost-effectiveness of sacubitril/valsartan in chronic heart failure with reduced ejection fraction
    Mcmurray, J. J. V.
    Cowie, M. R.
    Briggs, A.
    Taylor, M.
    Hancock, E.
    Trueman, D. David
    Haroun, R.
    Deschaseaux, C.
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 276 - 276
  • [50] Reply: Sacubitril/valsartan for Chagas' heart disease heart failure?
    Bocchi, Edimar Alcides
    Rassi, Salvador
    Guimaraes, Guilherme Veiga
    ESC HEART FAILURE, 2018, 5 (06): : 1072 - 1073
12345